92 related articles for article (PubMed ID: 16151774)
21. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
Kavanagh JP; Laube N
J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
[TBL] [Abstract][Full Text] [Related]
22. The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
Laube N; Glatz S; Hesse A
Urol Res; 2001 Feb; 29(1):45-9. PubMed ID: 11310215
[TBL] [Abstract][Full Text] [Related]
23. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
24. Determination of urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL applied to a family.
Laube N; Labedzke V; Hergarten S; Hesse A
J Chem Inf Comput Sci; 2002; 42(3):633-9. PubMed ID: 12086525
[TBL] [Abstract][Full Text] [Related]
25. Calcium oxalate crystallization in undiluted postprandial urine of healthy male volunteers as influenced by citrate.
Fan J; Schwille PO; Schmiedl A; Fink E; Manoharan M
Arzneimittelforschung; 2001 Oct; 51(10):848-57. PubMed ID: 11715639
[TBL] [Abstract][Full Text] [Related]
26. [Stress-related alteration of urine compositions: idiopathic CaOx stone formers, patients with chronic inflammatory bowel disease (CIBD) and healthy controls].
Berg W; Uhlemann C; Meissner A; Laube N
Urologe A; 2011 Dec; 50(12):1606-13. PubMed ID: 21989587
[TBL] [Abstract][Full Text] [Related]
27. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
Robertson WG
Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
[TBL] [Abstract][Full Text] [Related]
28. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
29. [On the uncertainty of measurements illustrated by the BONN Risk Index].
Laube N; Kleinen L
Urologe A; 2006 Feb; 45(2):189-94. PubMed ID: 16362381
[TBL] [Abstract][Full Text] [Related]
30. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
31. Nutrient intake and urine composition in calcium oxalate stone-forming dogs: comparison with healthy dogs and impact of dietary modification.
Stevenson AE; Blackburn JM; Markwell PJ; Robertson WG
Vet Ther; 2004; 5(3):218-31. PubMed ID: 15578454
[TBL] [Abstract][Full Text] [Related]
32. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
[TBL] [Abstract][Full Text] [Related]
33. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
34. [New diagnostic tool for individual monitoring of urolithiasis risk and other metabolic diseases].
Laube N; Klein F; Bernsmann F; Fisang C
Dtsch Med Wochenschr; 2014 Aug; 139(34-35):1721-5. PubMed ID: 25116022
[TBL] [Abstract][Full Text] [Related]
35. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
[TBL] [Abstract][Full Text] [Related]
36. Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones.
Jayachandran M; Yuzhakov SV; Kumar S; Larson NB; Enders FT; Milliner DS; Rule AD; Lieske JC
Orphanet J Rare Dis; 2020 Nov; 15(1):319. PubMed ID: 33176829
[TBL] [Abstract][Full Text] [Related]
37. Crystalluria: a clinically useful investigation in children with primary hyperoxaluria post-transplantation.
Jouvet P; Priqueler L; Gagnadoux MF; Jan D; Beringer A; Lacaille F; Revillon Y; Broyer M; Daudon M
Kidney Int; 1998 May; 53(5):1412-6. PubMed ID: 9573560
[TBL] [Abstract][Full Text] [Related]
38. Metabolic evaluation of urolithiasis patients from eastern Croatia.
Babić-Ivancić V; Avdagić SC; Serić V; Kontrec J; Tucak A; Füredi-Milhofer H; Marković M
Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
Serić V; Dutour-Sikirić M; Mihaljević I; Tucak-Zorić S; Bilić-Curcić I; Babić-Ivancić V
Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
[TBL] [Abstract][Full Text] [Related]
40. [Extended metabolic diagnosis of urolithiasis].
Laube N; Bradenahl J; Thomas E; Meissner A; Müller SC
Aktuelle Urol; 2006 Nov; 37(6):436-42; quiz 423-4. PubMed ID: 17099832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
